Ibn Sina Nature Cure Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
- Paid Up Capital ₹ 1.91 Cr
- Company Age 9 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -35.31%
- Ebitda 28.06%
- Net Worth -8.00%
- Total Assets -1.36%
About Ibn Sina Nature Cure
Ibn Sina Nature Cure Private Limited (ISNCPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 November 2015 (Nine years and three months 8 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 1.91 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ashfakh Ahmed and Ibrahim Lootah serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74900KA2015PTC083807
-
Company No.
083807
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
02 Nov 2015
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Ibn Sina Nature Cure?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashfakh Ahmed
|
Director | 02-Nov-2015 | Current |
Ibrahim Lootah
|
Director | 02-Nov-2015 | Current |
Financial Performance of Ibn Sina Nature Cure.
Ibn Sina Nature Cure Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 35.31% decrease in profit. The company's net worth dipped by a decrease of 8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ibn Sina Nature Cure?
In 2019, Ibn Sina Nature Cure had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Paintmytrip.Com Ota Private LimitedAshfakh Ahmed is a mutual person
-
Nelaap Farmers Producer Company LimitedAshfakh Ahmed is a mutual person
-
Fusav Engineering Devices Private Limited
Ibrahim Lootah is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ibn Sina Nature Cure?
Unlock and access historical data on people associated with Ibn Sina Nature Cure, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ibn Sina Nature Cure, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ibn Sina Nature Cure's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.